These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 901020)

  • 1. [Contribution to the kinetic study of urokinase and its possible application to the establishement of dosage regimens].
    Villaverde CA; Pla-Delfina JM; Escolar G; Badimón L; Valdecasas FG
    Arch Farmacol Toxicol; 1977 Apr; 3(1):75-7. PubMed ID: 901020
    [No Abstract]   [Full Text] [Related]  

  • 2. [Kinetics of urokinase hydrolysis of low molecular weight substrates].
    Maksimenko AV; Torchilin VP; Smirnov VN
    Biokhimiia; 1982 Mar; 47(3):405-8. PubMed ID: 7041994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Methods of urokinase administration based on its pharmacokinetics--pharmacokinetic approach].
    Matsuo O; Kosugi T; Mihara H
    Nihon Rinsho; 1979 Sep; 37(9):3357-61. PubMed ID: 522275
    [No Abstract]   [Full Text] [Related]  

  • 4. Kinetic studies of urokinase metabolism.
    Matsuo O; Mihara H
    Thromb Res; 1977 Oct; 11(4):531-41. PubMed ID: 918910
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasminogen activation activity of urokinase determined via a cascade enzymatic reaction system.
    Lee WC; Chuang CY; Chang RM
    Biochem Mol Biol Int; 1993 Apr; 29(6):1039-46. PubMed ID: 8330012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic study of the effect of heparin on the amidase activity of trypsin, plasmin and urokinase.
    Yomtova VM; Stambolieva NA; Blagoev BM
    Thromb Haemost; 1983 Jun; 49(3):199-203. PubMed ID: 6224310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the mechanism of the urokinase-catalysed hydrolysis of alpha-N-acetyl-L-lysine methyl ester.
    Petkov D; Stoineva I
    Biochim Biophys Acta; 1974 Dec; 370(2):546-55. PubMed ID: 4441491
    [No Abstract]   [Full Text] [Related]  

  • 8. Tissue-type plasminogen activator (t-PA) and single chain urokinase-type plasminogen activator (scu-PA): potential for fibrin-specific thrombolytic therapy.
    Collen D
    Prog Hemost Thromb; 1986; 8():1-18. PubMed ID: 3104986
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal clearance of urokinase.
    Matsuo O; Mihara H
    Nihon Ketsueki Gakkai Zasshi; 1977 Aug; 40(4):567-9. PubMed ID: 920060
    [No Abstract]   [Full Text] [Related]  

  • 10. [Activation of plasminogen and prothrombin by immobilized activators -- urokinase and thromboplastin (author's transl)].
    Rybák M; Coupek J
    Cas Lek Cesk; 1980 Oct; 119(40-41):1106-8. PubMed ID: 7026035
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combined effect of vitamin E and peroxidates of unesterified fatty acids on urokinase and histidase activity].
    Mkhitarian VG; Mezhlumian LM
    Zh Eksp Klin Med; 1976; 16(4):3-7. PubMed ID: 1016483
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of oral urokinase and its clinical application.
    Abe T; Kazama M; Naito I; Kinoshita T; Sasaki K
    New Istanbul Contrib Clin Sci; 1982; 13(3):161-70. PubMed ID: 6760114
    [No Abstract]   [Full Text] [Related]  

  • 13. [Joint effect of insulin, hydrocortisone and peroxidized unsaturated fatty acids on urokinase and histidase activity].
    Mkhitarian VG; Mezhlumian LM
    Zh Eksp Klin Med; 1974; 14(6):36-41. PubMed ID: 4456929
    [No Abstract]   [Full Text] [Related]  

  • 14. A quantitative assay for the activation of plasminogen by transformed cells in situ and by urokinase.
    Leytus SP; Peltz GA; Liu HY; Cannon JF; Peltz SW; Livingston DC; Brocklehurst JR; Mangel WF
    Biochemistry; 1981 Jul; 20(15):4307-14. PubMed ID: 7025895
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dosage and control of thrombolysis therapy using urokinase].
    Trübestein G
    Dtsch Med Wochenschr; 1980 May; 105(20):736-7. PubMed ID: 6989584
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dosage and control of thrombolysis therapy using urokinase].
    Tilsner V
    Dtsch Med Wochenschr; 1980 Apr; 105(17):618. PubMed ID: 6989581
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dosage and control of thrombolysis therapy using urokinase].
    Zimmermann R; Mörl H
    Dtsch Med Wochenschr; 1980 Mar; 105(12):419-20. PubMed ID: 6988188
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral urokinase: absorption, mechanisms of fibrinolytic enhancement and clinical effect on cerebral thrombosis.
    Abe T
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):122-36. PubMed ID: 2427393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Urokinase dosage in deep venous thromboses].
    Theiss W; Kriessmann A; Wirtzfeld A
    Dtsch Med Wochenschr; 1980 Jun; 105(24):873. PubMed ID: 6998691
    [No Abstract]   [Full Text] [Related]  

  • 20. The in vitro and in vivo behavior of urokinase immobilized onto collagen-synthetic polymer composite material.
    Watanabe S; Shimizu Y; Teramatsu T; Murachi T; Hino T
    J Biomed Mater Res; 1981 Jul; 15(4):553-63. PubMed ID: 7024280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.